Ads
-
Related paper
- Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
- Structure-Based Identification of Some Potential Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) With In-silico Assessment of Their Pharmacokinetic Features and Quantum Chemical Calculations
- Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
- Lung Cancer: Biomarkers, Tyrosine Kinase Inhibitors and Monoclonal Antibodies
- Epidermal Growth Factor Receptor Mutation and Lung Cancers, Current Evidence, a Brief Review
- Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia
- Over Expression of Apoptotic p53 and Epidermal Growth Factor Receptor in endometrial Cancer and Benign
- Study of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor Expression by Immunohistochemistry in Breast Carcinoma
- Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor (VEGF) expression in Sinonasal Inverted Papillomas
- Design, Synthesis and Biological Evaluation of Some New Derivatives of Azoles Bearing Pyrrolo [2, 3-d] Pyrimidine Nucleus as Janus Tyrosine Kinase Inhibitors for the Treatment of Auto Immune Disease